Renovo Skin Healing Drug Fails to Meet Main Goal in Phase II Trial

Renovo Group PLC’s skin healing drug Juvidex failed to meet its primary goal in a Phase II trial, but did meet a number of secondary endpoints.
proactiveinvestors